335 related articles for article (PubMed ID: 15466881)
1. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
2. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.
Annigeri R; Conly J; Vas S; Dedier H; Prakashan KP; Bargman JM; Jassal V; Oreopoulos D
Perit Dial Int; 2001; 21(6):554-9. PubMed ID: 11783763
[TBL] [Abstract][Full Text] [Related]
3. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
4. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
5. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
6. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
9. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
10. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients.
Pratt O
CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
12. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
14. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
Solares CA; Batra PS; Hall GS; Citardi MJ
Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
[TBL] [Abstract][Full Text] [Related]
16. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
Kingwatanakul P; Warady BA
Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
[TBL] [Abstract][Full Text] [Related]
18. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
19. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
